Use this page in order. Emergency priority comes first. If that does not take over, ask whether the symptom pattern or your individual context makes medical assessment the priority. Only after those boundaries are resolved should this page consider whether the remaining question is genuinely nonmedical.

STOP — EMERGENCY PRIORITY: The commercial task ends immediately.

PAUSE — MEDICAL ASSESSMENT PRIORITY: The next question belongs outside product research.

RETURN TO NONMEDICAL RESEARCH: The remaining question can return to category or product research, but this is not medical clearance.

Stop shopping when an emergency boundary takes priority

If dizziness or vertigo occurs with a source-supported emergency circumstance, the product decision ends. Stop shopping and call 911 or use emergency care.

Examples from MedlinePlus include:

  • chest pain or shortness of breath;
  • seizures;
  • weakness, inability to move an arm or leg, or changes in vision or speech.

These are examples, not a complete emergency checklist. Their absence does not establish safety or mean that medical care is unnecessary. MedlinePlus — Dizziness

If this STOP boundary owns the decision, there is no product-comparison step to complete here. The next action is outside the commercial journey.

Pause shopping when the symptom pattern belongs in medical assessment

Even when the emergency boundary above does not take over, continued product research can still be the wrong decision frame.

Pause shopping when the symptom pattern is:

  • worsening;
  • recurring or happening often;
  • persistent or not going away;
  • interfering with daily activities.

MedlinePlus supports provider assessment across these boundaries: worsening dizziness, dizziness that happens often, and vertigo that does not go away or interferes with daily activities. MedlinePlus — Dizziness MedlinePlus — Dizziness and Vertigo MedlinePlus — Vertigo-associated disorders

This does not identify the cause, assign an urgency level, or tell you which care setting to use. It changes one thing: PAUSE the shopping decision. The unresolved symptom question belongs in medical assessment rather than product comparison.

Pause when the supplement decision depends on your individual context

A generic product framework also stops being enough when the decision depends on personal medical context.

Pause generic supplement research when the unresolved question is about:

  • medicines or other supplements you use;
  • planned surgery;
  • pregnancy or nursing;
  • a medical or health condition that could affect suitability;
  • whether a supplement is personally suitable for you.

MedlinePlus advises provider contact when dizziness occurs after taking medicine. FDA and NCCIH also explain that supplements can interact with medicines, can matter around surgery, and can raise individualized questions in pregnancy, nursing, or certain medical conditions. MedlinePlus — Dizziness FDA — FDA 101: Dietary Supplements NCCIH — Some Medication-Supplement Interactions Can Be Serious NCCIH — Using Dietary Supplements Wisely

The purpose here is not to solve those questions. It is to recognize that they are individualized questions. PAUSE generic product research and move that question outside this article.

Why commercial materials cannot settle the medical question

A product page, label, marketing claim, testimonial, or product evidence page can describe a commercial proposition. It is not an individualized medical assessment, and it cannot determine the cause or personal medical significance of your dizziness or vertigo, or whether a supplement is right for you. FDA guidance itself directs consumers toward health professionals for individual benefits, risks, and suitability questions. FDA — FDA 101: Dietary Supplements

When the controlling uncertainty is medical or individualized, inspecting more commercial material does not resolve it. Shopping pauses.

Returning to nonmedical research is not medical clearance

RETURN TO NONMEDICAL RESEARCH means only that the remaining question is genuinely nonmedical and belongs back within VRHQ's category or product decision support. This boundary page is no longer the right tool for that remaining question.

It does not mean medical clearance, reassurance, safety, suitability, diagnosis or absence of disease, treatment appropriateness, supplement efficacy, clinician approval, or endorsement.

This page is not a complete emergency or medical-assessment checklist. The absence of one of its examples does not establish that medical care is unnecessary.

The useful question is therefore not whether you “passed” this page. It is: Is the remaining uncertainty now genuinely about category evidence or a particular product, rather than symptoms or individual medical context?

If the remaining question is category-level, continue with whether supplements are worth investigating further.

If you already have a particular product in front of you, continue with how to evaluate the specific vertigo supplement you are considering.

Those are neutral editorial research routes. They are not referrals, recommendations, or evidence of medical suitability.

Your next state: STOP, PAUSE, or RETURN TO NONMEDICAL RESEARCH

STOP — EMERGENCY PRIORITY

Meaning: The emergency boundary owns the decision.

Action: End the commercial task and call 911 or use emergency care as stated in the emergency section.

Navigation: None.

PAUSE — MEDICAL ASSESSMENT PRIORITY

Trigger: The symptom-pattern or individualized-context boundary owns the decision.

Meaning: The next question belongs outside commercial product research.

Action: Move the unresolved question into appropriate outside medical or professional assessment or context. This page does not choose a care setting for you.

Navigation: None. PAUSE may permanently end the shopping journey.

RETURN TO NONMEDICAL RESEARCH — REMAINING QUESTION IS NONMEDICAL

Trigger: The remaining uncertainty is genuinely about category evidence or a particular product, rather than symptoms or individualized medical context.

Meaning: This page releases that nonmedical question back to VRHQ's research scope.

Qualification: This is not medical clearance, reassurance, safety, suitability, diagnosis, treatment appropriateness, supplement efficacy, clinician approval, or endorsement.

Navigation: Only the two neutral editorial research routes in the return-to-research section above.

Sources

  • MedlinePlus — Dizziness. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/003093.htm
  • MedlinePlus — Vertigo-associated disorders. U.S. National Library of Medicine. https://medlineplus.gov/ency/article/001432.htm
  • MedlinePlus — Dizziness and Vertigo. U.S. National Library of Medicine / National Institutes of Health. https://medlineplus.gov/dizzinessandvertigo.html
  • FDA — FDA 101: Dietary Supplements. U.S. Food and Drug Administration. https://www.fda.gov/consumers/consumer-updates/fda-101-dietary-supplements
  • NCCIH — Know the Science: How Medications and Supplements Can Interact — Some Medication-Supplement Interactions Can Be Serious. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/know-science/how-medications-and-supplements-can-interact/some-medication-supplement-interactions-can-be-serious
  • NCCIH — Using Dietary Supplements Wisely. National Center for Complementary and Integrative Health. https://www.nccih.nih.gov/health/using-dietary-supplements-wisely